Obesity, metabolic syndrome impact breast cancer subtypes and mortality

In the Women's Health Initiative (WHI) randomized trial, a low-fat diet reduced breast cancer mortality, especially in women with more metabolic syndrome (MetS) components (obesity, high blood pressure, elevated blood sugar, and abnormal cholesterol). A recent analysis of WHI findings indicates that MetS and obesity each have different associations with breast cancer subtypes and mortality risk. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

The analysis included 63,330 postmenopausal WHI clinical trial participants without prior breast cancer, as well as normal entry mammograms and MetS scores (0–4). After a median follow-up of 23.2 years, there were 4,562 incident breast cancers and 659 deaths from breast cancer (breast cancer mortality).

A higher MetS score (3–4), regardless of obesity, was associated with more poor-prognosis, estrogen receptor (ER)-positive, progesterone receptor (PR)-negative breast cancers and a 44% higher risk of breast cancer mortality. Obesity, regardless of MetS score, was associated with more good-prognosis, ER-positive, PR-positive cancers. Only women with severe obesity (for example, a postmenopausal woman 5 feet, 6 inches tall, weighing >218 pounds) had a higher risk of breast cancer mortality.

Postmenopausal women with higher MetS scores are a previously unrecognized population at higher breast cancer mortality risk. Determination of MetS scores in the clinic requires only three questions regarding cholesterol, diabetes, and hypertension history as well as waist circumference and blood pressure measurements, which are commonly determined during routine visits." 

Rowan T. Chlebowski, MD, PhD, lead author of The Lundquist Institute

Source:
Journal reference:

Chlebowski, R. T., et al. (2024) Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women’s Health Initiative. CANCER. doi.org/10.1002/cncr.35318.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity